SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
A controlled, randomized, open-label, multicenter study evaluating if early initiation of everolimus and early elimination of cyclosporine in de novo heart transplant recipients can improve long-term renal function and slow down the progression of chronic allograft vasculopathy
Epistemonikos ID: f0a515a159dc2a070f1f90217ab49df175dcdaec
First added on: May 06, 2024